Showing 1,021 - 1,040 results of 1,061 for search '"lymphoma"', query time: 0.04s Refine Results
  1. 1021

    Response to Hydralazine-Valproate in a Patient with Mycosis Fungoides by Alfonso Dueñas-Gonzalez, Maria Teresa Vega, Déborah Martinez-Baños, Linda García-Hidalgo, Pedro Sobrevilla

    Published 2010-01-01
    “…Histone deacetylase (HDAC) inhibitors have shown significant activity in the treatment of cutaneous T-cell lymphomas (CTCL). The epigenetic alterations of CTCL not only are limited to altered histone acetylation but also include aberrant DNA gene methylation hence, the combination of an HDAC inhibitor with a DNA demethylating agent is a promising therapy to be tested. …”
    Get full text
    Article
  2. 1022

    Uncommon Presentation of a Benign Nasopharyngeal Mass in an Adolescent: Comprehensive Review of Pediatric Nasopharyngeal Masses by Victor M. Duarte, Yuan F. Liu, Nina L. Shapiro

    Published 2013-01-01
    “…When malignant, the most common lesions encountered are rhabdomyosarcomas, carcinomas, and lymphomas. We report a single case from a tertiary care institution of an adolescent male with an unusual presentation of a benign nasopharyngeal mass and provide a comprehensive review of pediatric nasopharyngeal masses. …”
    Get full text
    Article
  3. 1023

    CAR-T therapy toxicities: the importance of macrophages in their development and possible targets for their management by Joseph Norton, Patrick Stiff

    Published 2025-01-01
    “…Abstract CAR-T cell therapies have risen to prominence over the last decade, and their indications are increasing with several products approved as early as second line in Large B Cell non-Hodgkin Lymphomas. Their major toxicities are the cytokine release syndrome (CRS) and the Immune-effector Cell Associated Neurotoxicity Syndrome (ICANS). …”
    Get full text
    Article
  4. 1024

    Childhood Hypopigmented Mycosis Fungoides: A Rare Diagnosis by Cláudia Patraquim, Maria Miguel Gomes, Carla Garcez, Filipa Leite, Tereza Oliva, António Santos, Armando Pinto

    Published 2016-01-01
    “…Primary cutaneous lymphomas (PCL) are rare in pediatrics. Mycosis fungoides (MF) is the most frequent PCL diagnosed in childhood. …”
    Get full text
    Article
  5. 1025

    Host Epithelial Interactions with Helicobacter Pylori: A Role for Disrupted Gastric Barrier Function in the Clinical Outcome of Infection? by Andre G Buret, Jason P Fedwick, Andrew N Flynn

    Published 2005-01-01
    “…Infection of the human stomach with Helicobacter pylori may develop into gastritis, ulceration, adenocarcinoma and mucosal lymphomas. The pathogenic mechanisms that determine the clinical outcome from this microbial-epithelial interaction remain poorly understood. …”
    Get full text
    Article
  6. 1026

    CAR-T Therapy Beyond B-Cell Hematological Malignancies by Martina Canichella, Paolo de Fabritiis

    Published 2025-01-01
    “…Despite the advances of CAR-T cells in certain hematological malignancies, mostly from B-cell derivations such as non-Hodgkin lymphomas, acute lymphoblastic leukemia and multiple myeloma, a significant portion of other hematological and non-hematological pathologies can benefit from this innovative treatment, as the results of clinical studies are demonstrating. …”
    Get full text
    Article
  7. 1027

    Crystal Structures of Tcl1 Family Oncoproteins and Their Conserved Surface Features by John M. Petock, Ivan Y. Torshin, Yuan-Fang Wang, Garrett C. Du Bois, Carlo M. Croce, Robert W. Harrison, Irene T. Weber

    Published 2002-01-01
    “…Members of the TCL1 family of oncogenes are abnormally expressed in mature T-cell leukemias and B-cell lymphomas. The proteins are involved in the coactivation of protein kinase B (Akt/PKB), a key intracellular kinase. …”
    Get full text
    Article
  8. 1028

    Epstein-Barr Virus Infection in an Elderly Nonimmunocompromised Adult Successfully Treated with Rituximab by Jacob P. Smeltzer, Matthew T. Howard, Wilson I. Gonsalves, Thomas E. Witzig

    Published 2014-01-01
    “…In addition to causing a viral illness, it is also associated with various malignancies in particular B cell lymphomas and lymphoproliferative disorders. Differentiating between the two processes can be a diagnostic challenge. …”
    Get full text
    Article
  9. 1029

    Benign and non-neoplastic tumours of the duodenum by Wojciech Latos, Aleksandra Kawczyk-Krupka, Natalia Strzelczyk, Aleksander Sieroń, Grzegorz Cieślar

    Published 2019-12-01
    “…Among tumours the following should be mentioned – benign: adenomas, lipomas, haemangiomas, and leiomyomas; and malignant: malignant tumours of epithelial origin, primary gastrointestinal stromal tumours, neuroendocrine tumours and carcinoids, lymphomas, sarcomas, teratomas, and secondary metastases. …”
    Get full text
    Article
  10. 1030
  11. 1031

    DNA replication initiation drives focal mutagenesis and rearrangements in human cancers by Pierre Murat, Guillaume Guilbaud, Julian E. Sale

    Published 2024-12-01
    “…Sites of replication initiation impede nucleotide excision repair in melanoma and are off-targets for activation-induced deaminase (AICDA) activity in lymphomas. Using ductal pancreatic adenocarcinoma as a cancer model, we demonstrate that the initiation of DNA synthesis is error-prone at G-quadruplex-forming sequences in tumours displaying markers of replication stress, resulting in a previously recognised but uncharacterised mutational signature. …”
    Get full text
    Article
  12. 1032

    Gastric Collision Tumors: An Insight into Their Origin and Clinical Significance by Adamantios Michalinos, Anastasia Constantinidou, Michael Kontos

    Published 2015-01-01
    “…Tumors encountered are gastric adenocarcinomas colliding with lymphomas, gastrointestinal stromal tumors, squamous cell carcinomas, and neuroendocrine tumors. …”
    Get full text
    Article
  13. 1033

    Morphologic Features of Extrahepatic Manifestations of Hepatitis C Virus Infection by Huaibin M. Ko, Juan C. Hernandez-Prera, Hongfa Zhu, Steven H. Dikman, Harleen K. Sidhu, Stephen C. Ward, Swan N. Thung

    Published 2012-01-01
    “…Other HCV-associated entities include porphyria cutanea tarda, lichen planus, necrolytic acral erythema, membranous glomerulonephritis, diabetic nephropathy, B-cell non-Hodgkin lymphomas, insulin resistance, sialadenitis, sicca syndrome, and autoimmune thyroiditis. …”
    Get full text
    Article
  14. 1034

    HCV and Lymphoproliferation by Anna Linda Zignego, Carlo Giannini, Laura Gragnani

    Published 2012-01-01
    “…These latter range from benign, but prelymphomatous conditions, like mixed cryoglobulinemia, to frank lymphomas. Analogously with Helicobacter pylori related lymphomagenesis, the study of the effects of viral eradication confirmed the etiopathogenetic role of HCV and showed it is an ideal model for better understanding of the molecular mechanisms involved. …”
    Get full text
    Article
  15. 1035

    CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA by Ugo Testa, Elvira Pelosi, Germana Castelli, Alberto Fresa, Luca Laurenti

    Published 2024-04-01
    “…Among these new treatments, a potentially curative approach consists of the use of chimeric antigen receptor T (CAR-T) cell therapy, which achieved remarkable success in various B-cell malignancies, including B-cell Non-Hodgkin Lymphomas (NHLs) and B-acute lymphoblastic Leukemia (ALL). …”
    Get full text
    Article
  16. 1036

    Histopathological Spectrum and Immunohistochemistry Expression of Pediatric Solid Malignant Tumors: An Observational Study by Bhumika Patel, Jagadale Kunda, Reena Bharadwaj

    Published 2025-01-01
    “…Results: The top five categories of tumors were retinoblastomas, lymphomas, neuroblastomas, bone and soft tissue tumors, and renal and reproductive system tumors. …”
    Get full text
    Article
  17. 1037

    MicroRNAs as Haematopoiesis Regulators by Ram Babu Undi, Ravinder Kandi, Ravi Kumar Gutti

    Published 2013-01-01
    “…Aberrant expression of miRNAs was observed in hematological malignancies including chronic myelogenous leukemia, chronic lymphocytic leukemia, multiple myelomas, and B cell lymphomas. In this review we have focused on discussing the role of miRNA in haematopoiesis.…”
    Get full text
    Article
  18. 1038

    Oncolytic Virotherapy for Hematological Malignancies by Swarna Bais, Eric Bartee, Masmudur M. Rahman, Grant McFadden, Christopher R. Cogle

    Published 2012-01-01
    “…Hematological malignancies such as leukemias, lymphomas, multiple myeloma (MM), and the myelodysplastic syndromes (MDSs) primarily affect adults and are difficult to treat. …”
    Get full text
    Article
  19. 1039

    ANCA-Associated Vasculitides and Hematologic Malignancies: Lessons from the Past and Future Perspectives by Marco Folci, Giacomo Ramponi, Dana Shiffer, Aurora Zumbo, Michele Agosti, Enrico Brunetta

    Published 2019-01-01
    “…The purpose of this paper is to collect and summarize all evidences relating to an association between ANCA-associated vasculitides (AAVs) and hematologic malignancies, in the form of either a paraneoplastic vasculitis or leukemias and lymphomas developing on a preexisting vasculitis. Additionally, the role of cyclophosphamide in vasculitis treatment has been assessed and compared to rituximab. …”
    Get full text
    Article
  20. 1040